Current Intelligence Bulletins are prepared by the staff of the Division of Standards Development and Technology Transfer, NIOSH, (Robert A. Taft Laboratories, 4676 Columbia Parkway, Cincinnati, Ohio, 45226) and are distributed to representatives of organized labor, industry, public health agencies, academic institutions, and public interest groups as well as to those federal agencies, such as the Department of Labor, which have responsibilities for protecting the health of workers. It is our intention that anyone with the need to know should have ready access to the information contained in these documents; we welcome suggestions concerning their content, style, and distribution.
Because of the recent attention given to human exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD, "dioxin") contaminated materials and published reports on the toxicity of TCDD, NIOSH staff consider it necessary to present a review of the pertinent data and a summary of findings related to the human hazard potential of TCDD. Because of the compression in this bulletin of the voluminous literature on TCDD, it is suggested that readers wanting to know more of the details of the reported studies consult the appended references.
[signature] J. Donald Millar, M.D., D.T.P.H. (Lond.) Assistant Surgeon General Director, National Institute for Occupational Safety and Health Centers for Disease Control |
TCDD occurs as a contaminant of materials such as 2,4,5-trichlorophenol (TCP), 2,4,5-trichlorophenoxyacetic acid (2,4,5-t), and 2-(2,4,5-trichlorophenoxy)propionic acid (silvex). Occupational exposure may occur through contact with these materials during use or from the past contamination of worksites.
The National Institute for Occupational Safety and Health (NIOSH) recommends that TCDD be regarded as a potential occupational carcinogen, that occupational exposure to TCDD be controlled to the fullest extent feasible, and that decontamination measures be used for TCDD-contaminated work environments. This recommendation is based on a number of reliable studies demonstrating TCDD carcinogenicity in rats and mice.
TCDD is one of a family of isomers known chemically as dibenzo-p-dioxins. The chemical and physical properties are summarized in Table I. TCDD is a colorless crystalline solid at room temperature. It is sparingly soluble in most organic solvents and essentially insoluble in water. TCDD is stable to heat, acids, and alkali and will decompose when exposed to ultraviolet light, including sunlight.1
Chemical and Physical Properties of TCDD2,3
CAS Registry No.: | 1746-01-6 | ||||||||||||||||||||||
Empirical formula | C12H4Cl4O2 | ||||||||||||||||||||||
Percent by weight | C | 44.7% | |||||||||||||||||||||
0 | 9.95% | ||||||||||||||||||||||
H | l.25% | ||||||||||||||||||||||
C1 | 44.l% | ||||||||||||||||||||||
Molecular weight | 322 | ||||||||||||||||||||||
Vapor Pressure mm Hg at 25 °C | 1.7 X 10-6 | ||||||||||||||||||||||
Melting point, °C | 305 | ||||||||||||||||||||||
Decomposition temperature, °C | >700 | ||||||||||||||||||||||
Solubilities, g/liter | |||||||||||||||||||||||
| l.4
|
| O.72
|
| 0.57
|
| 0.37
|
| 0.05
|
| 0.01
|
| 0.11
|
| 2 X 10-7
| |
Formation and Use of TCDD
TCDD forms as a stable by-product or contaminant during the production of TCP. Run-away reactions at high temperature, in which excess TCDD was produced, have occurred at TCP production sites in the United States and elsewhere.4 Normally, TCDD persists as a contaminant in TCP in relatively small, variable amounts (0.07-6.2 mg/kg.5 TCP has been utilized primarily as a feedstock for production of the phenoxy herbicides 2,4,5-T and silvex, resulting in the contamination of these products with TCDD. Production of 2,4,5-T and silvex ceased in the United States in 1979. However, stockpiles of both products are still being distributed and used. TCP also is used in the production of hexachlorophene, a bactericide and fungicide.
The combustion of 2,4,5-T can result in its conversion to small amounts (0.6 ppt TCDD/1 ppm 2,495-T burned) of TCDD. Also, the burning or heating of commercial and purified chlorophenates and pyrolysis of polychlorinated biphenyls (PCBs) contaminated with trichlorobenzenes have resulted in the production of TCDD.6,7 The formation of TCDD from trace chemical reactions in fires has been postulated but has not been verified.8,9
Existing Regulations and Guides
No occupational exposure standard exists for TCDD. The United States Environmental Protection Agency (U.S. EPA) temporarily suspended or banned most uses of 2,4,5-T and silvex in 1979, although their use was allowed on sugarcane, orchards and for miscellaneous non-crop uses.10 On October 18, 1983 EPA published its intent to cancel registration of pesticide products containing 2,4,5-T and silvex and to prohibit the transfer, distribution, sale or importation of any unregistered pesticide product containing 2,4,5-T or silvex or their derivatives.11
Nature of Occupational Exposure to TCDD
It is not possible to estimate accurately the number of U.S. workers currently at risk of exposure to TCDD. Occupational exposure to TCDD may occur during production of TCP; in decontamination of worksites from prior production or use of TCP, 2,4,5-T, or silvex; from waste materials (such as reclaimed oil) contaminated with TCDD; or from cleanup after fires in transformers containing polychlorinated aromatics.
Dust or soil particles contaminated with TCDD can remain airborne or accumulate on indoor or outdoor work surfaces and may present a potential exposure hazard. Exposure to TCDD as a vapor will normally be negligible because of its low vapor pressure. Contact with TCDD-contaminated liquids is possible through the handling of drums or tanks containing the liquid or through dispersion of the liquid.
Acute and Chronic Toxicity
There is wide variation in the dosage of TCDD required to cause death among animal species (oral LD50 0.6-5,000 µg TCDD/kg body weight (bw)).12,13 Progressive weight loss with death several weeks later is reported to characterize the response in experimental animals after administration of a lethal dosage of TCDD.12,14,15 Animals given single or repeated oral dosages of TCDD of 0.1 to 25 µg/kg bw demonstrated increased liver weights and lipid accumulation, thymic atrophy, and histopathological changes in liver and thymus.12,16-18
TCDD is reported to be at least three times more potent than any other known compound in stimulating production of aminolevulinic acid synthetase (ALA), the rate-limiting enzyme in porphyrin and heme synthesis.19,20 Varied effects on hematological functions have been reported in rats and mice dosed with TCDD: increased numbers of erythrocytes and leucocytes, increased hemoglobin concentration, decreased blood platelets in rats,21,22 and decreased hemoglobin concentration in mice.23
Effects on Reproductive Function
TCDD administered at dosages of 0.125-3.0 ug TCDD/g bw to mice and rats induced fetotoxicity that included cleft palates and kidney anomalies,24-26 intestinal hemorrhages and excessive tissue/organ fluid (edema), and prenatal mortality.27,28
Impairment of reproduction has been reported for rats ingesting 0.01 µg TCDD/kg bw/day. Significant decreased fertility, litter size, number of pups alive at birth, postnatal survival, and postnatal body weight of pups were evident in two successive generations delivered from male and female rats that ingested TCDD 90 days prior to first mating, during pregnancies, and for the durations of time between pregnancies.29 No significant dose-related reproductive effects were observed in male mice treated with up to 2.4 µg TCDD/kg bw/day and mated with untreated female mice.30,31
Immunological Effects
TCDD induced immunological function alterations, expressed by decreased thymus-to-body weight ratios, in nursing newborn rats exposed through dosing of the lactating mother.32 Other reports have shown that pre- and post-natal maternal dosing of rats and mice with TCDD caused thymic atrophy and suppression of cellular immunity in the offspring.33 TCDD administered intraperitoneally or orally to mice induced a strong immunosuppressive effect on antibody production and cell-acquired immune responses.34
Mutagenic Effects
Results of mutagenicity tests are inconclusive. In two studies TCDD was mutagenic in Salmonella typhimurium TA 1532 without activation.35,36 In another study, which used a more sensitive mutant strain, Salmonella typhimurium TA 1537, TCDD was not a mutagen.37 There is weak evidence of chromosomal aberrations in bone marrow of rats given dosages of 0.25 to 4 µg TCDD/kg bw.38,39
Carcinogenic Effects
Male rats fed dosages of 0.001 µg TCDD/kg bw/week for 78 weeks and sacrificed at week 95 of the study showed a variety of neoplastic tumors (ear duct carcinoma; lymphocytic leukemia; kidney adenocarcinoma; malignant peritoneal histiocytoma; skin angiosarcoma; hard palate, tongue and nasal turbinate carcinoma).40 Female rats that had ingested TCDD for two years at a dosage of 0.1 µg/kg bw/day developed carcinomas of the liver and squamous cell carcinomas of the lung, hard palate, nasal turbinates, or tongue.41 Male and female rats orally dosed with 0.5 µg TCDD/kg bw/week for two years demonstrated neoplastic nodules of the liver and thyroid adenomas.42
Male mice fed dosages of TCDD of 0.05 or 0.5 µg/kg/week for two years developed liver cancer; female mice fed 0.2 or 2.0 µg/kg/week for the same duration developed liver cancer and thyroid follicular cell adenomas.42 TCDD applied to the skin of female mice for two years (0.005 µg/kg bw/application; 3 days/week) resulted in a significantly higher incidence (P=0.007) of skin cancers (fibrosarcomas) when compared to untreated controls. An increase in the same tumor type, although not statistically significant (p=0.084), was also observed in the male mice that received a maximum dosage of 0.001 µg TCDD per application.43
Human Health Effects
The only information on the health effects in humans from exposure to TCDD is from clinical or epidemiological studies of populations who were occupationally and non-occupationally exposed to 2,4,5-T and TCP contaminated with TCDD. Because of the coincidental exposure to 2,4,5-T and TCP and to other herbicides as well as to TCDD, it is not possible to attribute the observed health effects solely to TCDD exposure. To date, no studies of humans include a quantitation of exposure to TCDD.
Chloracne and Other Systemic Effects
Chloracne is a chronic and sometimes disfiguring skin eruption caused by exposure to halogenated aromatic compounds including TCDD. Chloracne is possibly a result of systemic effects of these compounds, although it also may occur as a contact dermatitis.44,45
There are numerous cases of chloracne reported following accidental exposure to chlorinated aromatic chemicals which were probably contaminated with TCDD.46-48 The most notable recent exposure occurred in Seveso, Italy in 1976.49 In most incidences of chloracne, there are a variety of signs and symptoms (ranging from gastrointestinal disturbances to metabolic disorders) which accompany the appearance of the skin eruptions and persist for varying lengths of time.50-54
Reproductive Effects In Humans
Reproductive effects resulting from possible human exposure to TCDD are inconclusive. Data on male workers who applied agricultural sprays of 2,4,5-T or who produced TCDD-contaminated materials are consistent with the animal data which suggest no reproductive effects in males from TCDD exposure.55-57 To date, no study of reproductive effects in women or in offspring of males or females with defined exposure to TCDD has been reported.
Studies of birth defects in populations that may have been exposed non-occupationally to TCDD have been conducted in Australia where a correlation was observed between 2,4,5-T use and seasonal variation in the rate of spinal cord and spine formation defects; no causal association could be drawn.58 In a similar study in Hungary, an increased incidence of congenital malformations including spine formation defects could not be correlated with increased use of 2,4,5-T.59 A study based on incomplete fetal tissue samples from the Seveso, Italy population found no mutagenic, teratogenic, or fetotoxic effects in 30 interrupted pregnancies and four spontaneous abortions in women believed to have been exposed to TCDD.60 A U.S. EPA study found a positive relationship between spontaneous abortions and 2,4,5-T use in the Alsea, Oregon area.61 The study, however, has been severely criticized because of its numerous limitations: inaccurate comparisons of the study and control areas; inaccuracies in the collection of data on spontaneous abortions; incomplete and inaccurate data on 2,4,5-T usage; and failure to recognize that the rate of spontaneous abortions was not greater than would be expected.62
Studies of Mortality and Carcinogenesis in Humans
Findings have been inconclusive in many mortality studies of workers with occupational exposure to TCDD-contaminated materials because of the small size of the study population and concomitant exposures to other substances
No excess mortality or tumor incidence was observed among Swedish railroad workers exposed to unknown amounts of 2,4-D, 2,4,5-T, and other herbicides but believed to have been exposed primarily to phenoxy acid herbicides for at least 45 days.63 In a subsequent analysis of mortality in this group of workers, 45 deaths (49 expected) were observed in the total population. A significant excess of tumors also was observed among those believed to be exposed primarily to Amitrol® (3-amino-1,2,4-triazole), a suspect carcinogen, as well as to phenoxy herbicides. Two cases of stomach cancer (0.33 expected) were observed among those exposed primarily to phenoxy herbicides.64
Among Swedish forestry workers exposed to phenoxy herbicide preparations, supervisors, who had more extensive exposure to herbicides than the other forest workers, had a nonsignificant excess of deaths from all cancers. Mortality associated with the presence of tumors was, however, lower than expected for the total group of exposed workers.65
In a group of 74 workers involved in an accident during TCP production in Germany, 21 deaths occurred during the following 27 years. Seven (7) malignant neoplasms vs. 4.2 expected and a significant excess of stomach cancer (3 observed vs. 0.61 expected) were observed.66
Several case control studies of cancer patients have yielded data on the carcinogenicity of phenoxyacetic herbicides. Two studies were conducted in Sweden following a clinical observation of patients with soft tissue sarcoma who had previous occupational exposure to the herbicides.67 The first study of 52 cases of soft tissue sarcoma concluded that the sarcoma cases were 5.3 times more likely than the 206 controls to have had occupational exposure to phenoxyacetic acids (primarily 2,4,5-T and 2,4-D).68 The second study of 110 cases of soft tissue sarcomas indicated that this population was 6.8 times more likely to have had exposure to phenoxyacetic acids than the 219 controls.69 In neither study was it possible to demonstrate the relative risk related to exposure to TCDD-contaminated 2,4,5-T because of the presence of impurities such as chlorinated dibenzodioxins and dibenzofurans which were part of the phenoxyacetic herbicides.
In other reports from Sweden, 11 of 17 patients with malignant lymphoma reported occupational exposures to phenoxyacetic acids or chlorophenols;70 a case control study with 169 malignant lymphoma cases found a significantly higher occupational exposure to phenoxyacetic acids (primarily 2,4,5-T, and 2,4-D) associated with the sarcoma cases than did the 338 controls. Analysis by individual herbicide exposure was not possible.71
Two additional studies conducted in Sweden for colon cancer and nasal and nasopharyngeal cancer did not demonstrate an elevated risk for occupational exposure to phenoxyacetic acids .72,73
Among four small groups of U.S. production workers exposed to TCP and 2,4,5-T a total of 105 deaths were observed.74-76 In these, three deaths were attributed to soft tissue sarcoma (43 times the number expected for this age group of U.S. white males.77 Later, four additional cases were reported to have soft tissue sarcomas.78-81 However, a detailed review of work records and expert review of pathological tissue specimens have shown only two of the seven cases with both confirmed exposure to TCP or 2,4,5-T and diagnosis of soft tissue sarcoma.82
Summary of Toxicity in Animals and Humans
TCDD causes a variety of systemic and immunological effects in animals with wide variation among species in the dosage required to cause death. Studies using rats and mice have demonstrated that TCDD is an animal teratogen and carcinogen. Results of tests for mutagenicity are inconclusive.
Humans exposed to materials reported to be contaminated with TCDD have developed chloracne and other signs of systemic poisoning. Soft tissue sarcoma has been observed in excess among workers exposed to phenoxy herbicides. These data are inconclusive regarding TCDD toxicity in humans because the populations studied had mixed exposures making causal relationships between exposure and effect unclear. The data are, however, suggestive of an association between exposure to phenoxyacetic herbicides contaminated with TCDD and excess lymphoma and stomach cancer. Attempts to associate reproductive effects with TCDD exposure are inconclusive because of the inadequately defined populations studied and the difficulties of defining exposure.
Because of the variety of situations likely to be encountered in TCDD-contaminated worksites, it is not possible to offer in this bulletin detailed procedures for assessing exposures or decontamination. Based on NIOSH hazard evaluations of TCDD-contaminated sites, the following general guidelines are recommended until more specific procedures can be developed.86,87
Assessment of Exposure
Workers may be exposed to TCDD derived from a variety of sources: the production of TCP, residues from prior production or use of 2,4,5-T or silvex, waste materials contaminated by TCDD, or contamination resulting from transformer fires. The first step in assessing workplace contamination should be environmental sampling to determine the presence of TCDD contamination, keeping in mind the possible routes of exposure, with later sampling conducted to define the quantity of TCDD in the environment. The assessment may include sampling of soil and settled dust for TCDD, air sampling for TCDD-contaminated particles, and wipe sampling of surfaces.86,87
Decontamination and Worker Protection Programs
In general, decontamination procedures must provide an organized process in which levels of contamination are reduced. This requires containment, collection, and disposal of contaminated solutions and residues generated during the cleanup. Separate facilities should be provided for decontamination of large equipment.
Each stage of decontamination, such as gross decontamination and repetitive wash/rinse cycles, should be conducted separately, either by using different locations or by spacing in time. Personnel decontamination locations used should be physically separated to prevent cross-contact and should be arranged in order of decreasing level of contamination. Separate entry/exit routes and locations should be provided for workers when it is necessary to isolate them from different contamination areas containing incompatible waste. Entry and exit points to these areas should be well marked and controlled. Access to the decontamination area should be separate from the path between the contaminated and clean areas. Dressing stations for entry should be separate from re-dressing areas for exit.
Protective Clothing and Equipment
All workers who may be exposed to TCDD should be equipped with adequate chemical protective clothing and equipment to ensure their protection. In the selection of protective clothing, consideration should be given to the utilization of disposable apparel due to the uncertainty of decontamination of clothing.
The protective apparel should consist of both outer and inner garments. The outer garments should consist of a zippered coverall with attached hood and draw string or elastic sleeves, gloves and closure boots. If exposure is to particulate or dust, the coveralls should be made of a non-woven fabric such as spunbonded polyethylene, Tyvek®. In cases of exposure to liquids, the coveralls, gloves and boots should be made of chemically resistant materials such as disposable laminates, e.g., Saranax® coated Tyvek®, or synthetic elastomers such as butyl, nitrile or neoprene rubber. The inner garments should consist of cotton coveralls, undershirts, undershorts, gloves, and socks and should be disposed of after use. The effectiveness of the protective clothing should be evaluated under simulated use conditions, regardless of the type of clothing used. All disposable clothing should be placed in marked and approved containers and disposed of appropriately. All reusable clothing and equipment should be thoroughly cleaned and checked for residual contamination before reuse or storage.
Respiratory Protection
The use of respiratory protection requires that a respiratory protection program be instituted according to the requirements of 29 CFR 1910.13488 and that the respirators have been approved by the Mine Safety and Health Administration (MSHA) and by NIOSH. This program should include training on proper fit testing and use and procedures for respirator maintenance, inspection, cleaning and evaluation.
For situations where TCDD contamination is low (e.g., exposure to dust contaminated with low levels of TCDD), air purifying respirators should provide sufficient protection until the extent and characterization of the exposure can be determined. Where quantities of materials highly contaminated with TCDD have been released and have contaminated an area (e.g., production accidents), all workers who may be exposed to TCDD should wear respirators that consist of a self-contained breathing apparatus with a full facepiece operated in pressure-demand or other positive pressure mode. An alternate method utilizes a combination Type C supplied air respirator, with full facepiece, operated in pressure-demand mode and equipped with auxiliary positive pressure self-contained air supply.
Post-Decontamination Testing
The adequacy of the decontamination effort should be determined by conducting follow-up sampling and analysis of the contaminated areas and protective equipment. This testing should be conducted as each area is decontaminated and after the entire facility has been cleaned.
Copies of this and other NIOSH documents are available from:
This page was last updated: 21, 1997
Go back to the NIOSH home page or to the CDC home page.